Scientific Advisory Board

• Professor of Neurology, Harvard Medical School
• Principal Investigator, Neurology, Massachusetts General Hospital

A physician by training, Dr. Belpulsi has over 13 years of clinical research trial experience and currently holds the title of Medical Director at ICON plc. Dr. Belpulsi has worked in both Academic and Pharmaceutical/Biotech settings, developing and managing multiple phases of human clinical trials, both drug and device driven, from concept thru post market approval. In addition to an experienced Scientific Advisory Board member, she holds positions on both DMC and DSMB committees and is published in multiple peer reviewed journals.

Dr. Belpulsi is a poised communicator with an extraordinary commitment to advancing patient care and the science of medicine thru active engagement and meaningful dialogue with medical and scientific professionals.

• Fellow of The Faculty of Pharmaceutical Medicine of the Royal College of Physicians
• Former Senior Medical Advisor in the Division of Clinical Development at BARDA and Senior Policy Analyst, Division of International Health Security (Office of The ASPR, U.S. Department of Health and Human Services)
• Co-lead of the WHO Ebola Epidemic Global Experimental Therapeutics & Vaccines R&D Response
• Co-discoverer of the mechanism of action of a novel class of drugs, the 5-HT3 receptor antagonist anti-emetics
• Honored by H. M. Queen Elizabeth II and appointed Officer of the Most Excellent Order of The British Empire for services to international security in the field of biological weapons intelligence

• Professor of Anesthesiology, Neurology, Psychiatry, and Experimental Therapeutics at the University of Rochester School of Medicine
• Director of the Anesthesiology Clinical Research Center

Expert in Autonomic & Peripheral Nerve Disorders

• Professor of Neurology, Harvard Medical School
• Staff Neurologist and Director of the Center for Autonomic and Peripheral Nerve Disorders at Beth Israel Deaconess Medical Center, Boston

• Regents Professor of Medicinal Chemistry, University of Minnesota
• Director of the Institute for Therapeutics Discovery and Development

• Nick and Sue Hellman Distinguished Professor, and Professor of Medicine, Microbiology and Immunology at UCSF
• The founding and emeritus director of the Gladstone Institute of Virology and Immunology, an institute he directed for 28 years 
• Director of the Michael Hulton–Gladstone Center for HIV Cure Research
• Recognized by the Institute for Scientific Information as one of the 100 most-cited scientists in the world with more than 400 scientific manuscripts published

• Director, Banner Alzheimer's Institute, Arizona
• Research Professor of Psychiatry, University of Arizona College of Medicine